Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs YieldMax MSTR Option Income Strategy ETF (MSTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs YieldMax MSTR Option Income Strategy ETF — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while YieldMax MSTR Option Income Strategy ETF trades at $15.71 (market cap $1.06B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 11.9× YieldMax MSTR Option Income Strategy ETF's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and YieldMax MSTR Option Income Strategy ETF for 30 Days on average.
| HALO | MSTY | |
|---|---|---|
Market Cap | $12.58B | $1.06B |
Volume | 2,179,278 | 2,402,888 |
Sector | Health | Income / Options Overlay |
52-Week High | $115.22 | $67.85 |
52-Week Low | $61.63 | $11.55 |
Typical Hold Time | 1 Days | 30 Days |
Enterprise Value | $14.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MSTY trades at $15.66, down 1.07% with a bearish technical outlook. The ETF shows significant distribution activity but faces fundamental challenges with declining NAV. Recent articles highlight both the high distribution yield appeal and concerns about principal erosion, creating mixed sentiment among investors.
The outlook remains cautious with high distribution rates offset by NAV decline risks. Investment opportunity exists for income-focused investors, but requires careful monitoring of volatility and distribution sustainability. Key risks include continued principal erosion and dependence on MSTR's price volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About YieldMax MSTR Option Income Strategy ETF
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →
